Unfractionated Heparin for Hemodialysis: Still the Best Option
- 1 September 2010
- journal article
- review article
- Published by Wiley in Seminars in Dialysis
- Vol. 23 (5) , 510-515
Abstract
Unfractionated heparin (UFH) is the anticoagulant of choice for most maintenance hemodialysis units in the United States. Low molecular weight heparin (LMWH) is the norm in Western Europe, but is not approved for this indication in the United States. UFH is likely to remain the agent of choice in the United States because of its relative ease of use, safety, and low cost. Coating tubing and dialyzers with heparin is now possible, but systemic anticoagulation with heparin is usually still required. The additional cost of this innovation does not yet justify its use. Side effects of both UFH and LMWH include heparin‐induced thrombocytopenia, hypertriglyceridemia, and hyperkalemia. It is uncertain whether osteoporosis is an important side effect, as vitamin D deficiency, secondary hyperparathyroidism, age, and debility are confounding factors. When UFH poses a risk or its use is contraindicated, e.g., after development of heparin‐induced thrombocytopenia, the use of direct thrombin inhibitors, regional citrate anticoagulation, citrate dialysate, and heparin‐free dialysis may be appropriate.Keywords
This publication has 49 references indexed in Scilit:
- Increased Efficiency of Hemodialysis with Citrate DialysateClinical Journal of the American Society of Nephrology, 2009
- Dialysate … Ho-Hum!Clinical Journal of the American Society of Nephrology, 2009
- Review article: Low‐molecular‐weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatmentsNephrology, 2009
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisNew England Journal of Medicine, 2009
- Argatroban Anticoagulation in Renal Dysfunction: A Literature AnalysisNephron Clinical Practice, 2008
- Lipoprotein Metabolism and Lipid Management in Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2007
- National survey of heparin-induced thrombocytopenia in the haemodialysis population of the UK populationNephrology Dialysis Transplantation, 2007
- Hemodialysis for patients bleeding or at risk for bleeding, can be simple, safe and efficientClinical Nephrology, 2004
- Heparin free dialysis: Comparative data and results in high risk patientsKidney International, 1987
- Heparin-induced osteopenia in pregnancy.BMJ, 1980